Rock Springs Capital LLC
Insider CIK 1735397 · AVIR 10% owner · FIXX 10% owner · IMRA 10% owner · INZY 10% owner · THRX 10% owner · XLO 10% owner · VERV 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 1,437,297 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 7,186,490 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-26 | 756,472 | — | $0 | 756,472 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-26 | 151,294 | — | $0 | 151,294 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy | 2021-10-26 | 2021-10-26 | 500,000 | $16.00 | $8.00M | 1,256,472 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-14 | 349,320 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-14 | 87,329 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion | 2021-10-12 | 2021-10-14 | 349,320 | — | $0 | 349,320 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion | 2021-10-12 | 2021-10-14 | 87,329 | — | $0 | 87,329 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2021-10-12 | 2021-10-14 | 250,000 | $16.00 | $4.00M | 599,320 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 5,151,043 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 1,416,023 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 152,926 | — | $0 | 152,926 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2021-06-21 | 2021-06-22 | 370,000 | $19.00 | $7.03M | 926,298 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 556,298 | — | $0 | 556,298 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-04 | 890,313 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-04 | 104,340 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-04 | 178,063 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-04 | 521,703 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion | 2020-11-03 | 2020-11-04 | 1,412,016 | — | $0 | 1,412,016 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion | 2020-11-03 | 2020-11-04 | 282,403 | — | $0 | 282,403 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | P Buy | 2020-11-03 | 2020-11-04 | 242,708 | $24.00 | $5.82M | 1,654,724 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | P Buy | 2020-11-03 | 2020-11-04 | 7,292 | $24.00 | $175.0K | 289,695 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 3,496,504 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 24,000 | $16.00 | $384.0K | 1,067,884 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 576,000 | $16.00 | $9.22M | 1,043,884 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 467,884 | — | $0 | 467,884 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 1,722,222 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 273,411 | — | $0 | 273,411 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2020-03-16 | 2020-03-16 | 250,000 | $16.00 | $4.00M | 523,411 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 395,845 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2018-04-02 | 2018-04-04 | 250,000 | $16.00 | $4.00M | 645,845 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 395,845 | — | $0 | 395,845 | SEC↗ |